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Sunday, February 26, 2012 111acultures of human airway smooth muscle cells endogenously expressing
GABAA channels composed of a4, a5 b3 g1, g2, d and q subunits. We obtained
success rates above 95% for transiently or stably transfected HEK cells and fro-
zen ‘‘ready to assay’’ HEK cells expressing GABAA channels. Tissue-derived
immortalized cultures of airway smooth muscle cells exhibited a slightly lower
recording success rate of 75% using automated patch, which was much higher
than the 5% success rate using manual patch clamp. Primary cells harvested
from tissue yielded 30% success on this automated electrophysiology platform.
In all cases, both responses to agonist (EC50 measurements) and pharmacology
of GABAmodulators and inhibitors compared well to previously reported man-
ual patch results. The data presented here demonstrates that both the biophysics
and pharmacologic characterization of GABAA channels in a wide variety of
cell formats can be performed on this automated patch clamp system. This au-
tomated approach exhibited a much higher success rate, lower variability, and
higher experimental throughput as compared to manual patch clamp
techniques.
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Missense polymorphisms or variants that affect function and/or expression of
GABAA receptors (GABARs) have been associated with idiopathic generalized
epilepsies (IGEs) in GABRA1, GABRA6, GABRB3, GABRG2 and GABRD
genes. Three separate IGE-associated mutations were identified in GABAR
subunits (b3(G32R), a6(Q237R) and g2(K328M)), which represent a large
range of GABARs in the nervous system. We sought to investigate the contri-
butions of these mutations into the assembly and function of GABARs. Homol-
ogy modeling suggested that G32R is located within the N-terminal a-helix b3
subunit domain, and Q237R and K328M are located within the pre-M1 segment
of the N-terminal a6 subunit domain and the M2-M3 loop of the N-terminal g2
subunit domain, respectively. We studied gating properties and surface expres-
sion of wild type (wt) a1b3g2, a6b2g2, a1b2g2 and mutant a1b3(G32R)g2,
a6(Q237R)b2g2, a1b2g2(K328M) receptors expressed in HEK293T cells.
We found that the mutations share common gating defects, but distinctive traf-
ficking defects. Thus, mutant b3(G32R) subunits displayed a mixed profile,
causing both gating and trafficking defects of a1b3g2 receptors, whereas mu-
tant a6(Q237R) and g2(K328M) subunits caused exclusive channel gating de-
fects of a6b2g2 and a1b2g2 receptors. Unexpected, homology modeling
predicted that the b3(G32R) mutation affects a salt bridge across the g2/b3 sub-
unit interface, which underlies an assembly motif reported to be essential for
inter-subunit interactions in assembled receptors. In contrast, a6(Q237R) and
g2(K328M) subunit mutations are predicted to interact with residues in Pre-
M1 domain, M2-M3 loop and Cys-loop of a6 and g2 subunits that are critical
for desensitization-deactivation coupling of GABARs.
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A new model for the gamma-aminobutyric acid class A (GABAa) receptor is
presented, based on recent crystal structures of the homologous eukaryotic
GluCl channel (3RHW). The models suggest an additional disulfide bridge in
the transmembrane domain of both alpha and gamma (but not beta) subunits.
Models for the GABAa receptor in complex with steroid or steroid-like mod-
ulators such as cholesterol, pregnenolone, and thyroid hormone have also
been developed, based on ivermectin sites in PDB:3RHW and mutagenesis
studies. Extended molecular dynamics simulations of these models indicate sta-
ble binding interactions between the modulator and the receptor, with moderate
adjustment of modulator orientation. Hydrogen bonding patterns between mod-
ulator and receptor polar groups are shown to be modulator-dependent; these
results will be compared to prevailing hypotheses for essential pharmacophores
in modulation of GABAa receptors by neurosteroids.
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Massachusetts, Amherst, Amherst, MA, USA.GABA is the main inhibitory neurotransmitter in the brain, acting primarily at
ionotropic GABAA receptors. The a subunit is critical in determining GABAA
receptor functional properties and pharmacological regulation. There are six
a subunit subtypes that are differentially expressed in the nervous system but
few selective antagonists are available to dissect the functional role of those
subtypes in neurons. We have therefore engineered a subunit specific light in-
hibited GABAA receptors (Li-GABARs). We generated a subunits with a cys-
teine mutation that allows attachment of a photoswitchable tethered ligand
(PTL) consisting of a cysteine reactive maleimide group, a photoisomerizable
azobenzene core and a variable GABAR ligand. Using cysteine-scanning mu-
tagenesis we identified optimal photoswitch attachment sites near the GABA
binding pocket for both a1 and a5 subunits, and tested multiple PTLs to pro-
duce maximal light dependent block of GABAR activity while minimally af-
fecting basal receptor properties. We recorded from hippocampal slices
expressing Li-GABARs and found evidence that a5, but not a1 containing re-
ceptors counteract NMDA receptor dependent synaptic depolarization. This
novel interaction could provide a basis for the regulation of synaptic plasticity
and memory by a5 receptors. This approach in general provides a strategy to
study the role of specific GABAA receptor subunits and their importance in
neuronal function and disease.
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GABAA-receptors (GABARs) are chloride ion channels in the ‘cys-loop recep-
tor’ superfamily that are major inhibitory neuroreceptors. Upon agonist binding,
GABARs open and increase intraneuronal chloride ion concentration, hyperpo-
larize the cell and inhibit neural transmission. Reducing agents will break the di-
sulfide bonds in the cys-loop of the receptor. Indeed, it has been speculated that
sulfhydryl compounds modify proteins via thiol/disulfide redox reactions and
serve as neuromodulators (1). Reducing reagents were found to decrease the
GABA EC50 in the highly homologous GABAC-receptor, while oxidizing
reagents increased the EC50 (2). Conversely, conflicting findings suggests the
mechanism of action of redox modulation does not alter GABAR agonist-
binding affinity (3). However, studies are complicated by the fact that mutagen-
esis of the cysteines commonlyproduces failure of subunit assembly (4). Thus, to
investigate the effect of disulfide bond breakage on the receptor we generated
various GABAR homologymodels with and without disulfide bonds. These sys-
tems were subjected to ligand docking and extensive molecular dynamics sim-
ulations to determine if the GABA affinity was modulated. This work
performed under the auspices of the U.S. Department of Energy by Lawrence
Livermore National Laboratory under Contract DE-AC52-07NA27344.
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GABAA receptors belong to the family of pentameric ligand-gated ion chan-
nels (LGIC), which are involved in fast inhibitory neurotransmission. GABAA
receptors are allosterically modulated by benzodiazepines, general anesthetics
and alcohols. In this study, we investigate the effects of a range of general an-
esthetics, alcohols and non-competitive inhibitors on ELIC, which is a recently
characterized prokaryote homolog of GABAA receptors. We used two-
electrode voltage clamp recordings to identify ELIC modulators from a library
of compounds including chlorpromazine, memantine, picrotoxin, etomidate,
DMCM and brominated derivatives of alcohols and chloroform. X-ray crystal
structures of ELIC in complex with different modulators reveal the molecular
architecture for ligand recognition. Consistent with the observation that
112a Sunday, February 26, 2012allosteric modulators bind at multiple binding sites, we find ligands at different
sites in the channel pore, transmembrane domain and ligand-binding domain.
In combination with mutagenesis in eukaryote receptors, we probe the impor-
tance of homologous residues involved in ligand contacts. Together, our results
provide a framework for structure-based design of new allosteric modulators
targeting different sites in pentameric ligand-gated ion channels.
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The 5-HT3 serotonin receptor belongs to the family of pentameric ligand-gated
ion channels (LGIC). A wealth of structural information on molecular recogni-
tion of nicotinic ligands has emerged from high-resolution co-crystal structures
of acetylcholine binding proteins (AChBPs), which are homologous to the ex-
tracellular domain of the nicotinic acetylcholine receptor. Such information is
currently missing for other members of the LGIC family, including the 5-HT3
receptor. To overcome this limitation, we used a rational approach to engineer
a binding protein with ligand recognition properties similar to the 5-HT3 recep-
tor. Amino acids contributing to binding site loops A-F in AChBP were
substituted to their corresponding residues in the 5-HT3 receptor and the effect
of these substitutions were characterized with a competitive binding assay us-
ing 3H-granisetron. We present crystal structures of a binding protein chimera
in complex with agonists and antagonists of the 5-HT3 receptor. Together, this
information provides a structural framework for understanding ligand recogni-
tion in the 5-HT3 receptor.
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The Serotonin 3a Receptor (5HT3aR) is a pentameric ligand gated ion channel
found in the central and peripheral nervous systems and implicated in numerous
diseases. In previous studies with the endogenous agonist serotonin, we have
identified two interactions critical for receptor function: a cation-p interaction
atW183 in loopBand ahydrogenbondatE129 in loopA.Hereweemploymutant
cycle analyses utilizing conventional and unnatural amino acidmutagenesis to in-
vestigate howa third residue,D124of loopA, orients the aforementioned residues
for proper receptor function. We also identify differences in receptor binding
and the initiation of channel gating between serotonin and the competitive partial
agonist m-chlorophenylbiguanide (mCPBG) at these and adjacent residues.
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Despite high sequence identity, pentameric ligand-gated ion channels exhibit
remarkable diversity in function with anionic/cationic channels that are either
potentiated or inhibited by allosteric ligands. The recently available structures
of bacterial homologs of Cys-loop receptors provide an excellent framework
for understanding this allosteric modulation and function, but the modeling
can be complex; our earlier simulations of the prokaryotic anionic glycine re-
ceptor (GlyR) suggest inter-subunit binding for ethanol (Murail, Biophys J 100,
1642, 2011), which at first sight appears to be incompatible with the experimen-
tal Gloeobacter violaceus (GLIC) ligand-gated ion channel structure showing
binding intra-subunit.
Here, we present new simulations of GLIC that confirm the occurrence of mul-
tiple binding sites by showing intra-subunit binding for ethanol. By experimen-
tally introducing the single-site F238A mutation in GLIC we can turn it into
a highly ethanol-sensitive channel (Howard, PNAS 108, 12149, 2011), similar
to GlyR, and simulations of the mutated species confirm the occurrence of mul-tiple binding sites. To critically test the results, we performed extensive docking
and free energy calculations to identify alcohol-binding sites and determine their
affinity. In the wild-type GLIC, short alcohols preferentially bind intra-subunit,
with a very weak binding site inter-subunit. However, with the F238A mutation
the inter-subunit site achieves a significantly lower free energy, and even be-
comes the highest-affinity site in the channel for some alcohols.
These results suggest a new model for pentameric ligand-gated channel potentia-
tionand inhibition,where the intra-subunit cavitywould control inhibition, and the
inter-subunit cavity potentiation. The possibility of allosteric ligands interacting
with both cavities - or even a singlemolecule stretching fromone site to the other -
offers an attractive explanation for the complex functional dynamics of ligand-
gated ion channels as well as an potential explain for the alcohol cutoff effect.
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Modulators of ligand gated ion channel (LGIC) activity are being actively de-
veloped by a number of leading pharmaceutical companies. Electrophysiology
assays remain the gold standard for determining functional compound effects
on these targets, and pose unique challenges due to the need for accurate tem-
poral control of agonist and compound application.
In this study we present results from complex assays enabled by a novel micro-
fluidic automated patch clamp platform. The assay development process
include evaluation of a number of protocols including pre-incubation, co-appli-
cation, and open channel modulation modalities. The data includes case studies
from GABAA, nicotinic and NMDA receptors and trade-offs between the dif-
ferent available measurement modalities developed.
567-Pos Board B353
Agonist Interactions and Selectivity in Inhibitory Cys-Loop Ligand-Gated
Ion Channels
Han Shen Tae, Brett A. Cromer.
RMIT University, Bundoora, Australia.
Cys-loop ligand-gated ion channels constitute one of two major superfamilies
of receptors mediating rapid chemical synaptic transmission in the central ner-
vous system. Mammalian members of the superfamily include cation selective
channels that are receptors for excitatory neurotransmitters, acetylcholine and
serotonin, and anion selective channels that are receptors for inhibitory neuro-
transmitters, GABA and glycine. Structural information from snail acetylcho-
line binding proteins (AChBP), torpedo acetylcholine receptors provided
a clear picture of the acetylcholine-binding site, including the conserved aro-
matic box which forms cation-pi bonds with bound agonists. From AChBP-
based homology models, we proposed (Cromer 2002) that the 3-dimensional
position of one of the aromatic box residues is replaced with an acidic residue
in inhibitory receptors for GABA (GABAA/CR) and glycine (GlyR). Further
that this residue forms a salt-bridge interaction with the cation group of bound
agonists and is important for selectivity for primary amine agonists, such as
GABA and glycine, over bulkier quaternary amines, such as acetylcholine.
We now present evidence in support of this hypothesis, particularly using the
homopentameric Rho1 GABA receptor (GABAC) as a model for the broader
family of inhibitory Cys-loop LGICs. We also present evidence for a series
of other interactions in the agonist-binding site of inhibitory Cys-loop LGICs
that are determinants of selectivity between agonists of different size, such
as glycine versus GABA. These results are consistent with our initial hypoth-
esis and provide a more detailed understanding of agonist-receptor interactions
in inhibitory Cys-loop ligand-gated ion channels.
Cromer, B. A., Morton, C. J. & Parker, M. W. (2002). Anxiety over GABA(A)
receptor structure relieved by AChBP. Trends Biochem Sci 27, 280-7.
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The bacteriumErwinia chrysanthemi ligand gated ion channel (ELIC) is a proto-
type for Cys-loop receptors, including nicotinic acetylcholine receptors
(nAChRs). We co-crystallized ELIC with acetylcholine, an endogenous agonist
of nAChRs, and solved the crystal structure to a resolution of 2.9 A˚. Acetylcho-
line binds to the orthosteric agonist site for Cys-loop receptors. Upon acetylcho-
line binding, loop C exhibits a substantial contraction with a profound reduction
in flexibility. Conformational changes in nearby regions of the ligand-binding
domain are also observed. However, no substantial reorganization in the pore
